Author: Manuel Saenz De Viteri (Spain)
Co-authors: Valentina Bilbao Maravé, Jorge Gonzalez Zamora, Miriam De la Puente Carabot, Manuel Landecho, Javier Zarranz-Ventura, Alfredo García Layana
Purpose
The purpose of this study was to evaluate the presence of retinal and microvascular alterations in COVID-19 patients with bilateral pneumonia due to SARS-COV-2 that required hospital admission and compare this with a cohort of age and sex matched controls.
Setting/Venue
Cases were selected from a series of COVID-19 bilateral pneumonia patients, with at least one SARS-COV-2 positive polymerase chain reaction (PCR) test, and admitted at the Clínica Universidad de Navarra (Pamplona, Spain) during March and April 2020. Controls were obtained from a large optical coherence tomography angiography (OCTA) database at Hospital Clinic (Barcelona, Spain) from previous research projects.
Methods
Cross-sectional, consecutive case-control series. COVID-19 bilateral pneumonia patients underwent retinal imaging 14 days (n=25) and 6 months (n=17) after hospital discharge with structural optical coherence tomography (OCT) and OCTA measurements. Vessel density (VD) and foveal avascular zone (FAZ) area were evaluated in the superficial, deep capillary plexus (SCP, DCP), and choriocapillaris (CC)
Results
14 days after discharge, COVID-19 patients presented significantly thinner ganglion cell layer (GCL) (p = 0.003) and thicker retinal nerve fiber layer (RNFL) compared to controls (p = 0.048), and this RNFL thickening was greater in COVID-19 cases with cotton wool spots (CWS), when compared with patients without CWS (p = 0.032). In both SCP and DCP, COVID-19 patients presented lower VD in the foveal region (p < 0.001) and a greater FAZ area than controls (p = 0.007). 6 months after discharge, the parafoveal RNFL and GCL were significantly thinner in COVID-19 patients at 6 months compared to 0 months (p = <0.001 in both cases). In the optic nerve analysis, a significantly thinner RNFL was observed (p = 0.006) but persisted significantly thickened, compared to controls (p = 0.02). The vascular density (VD) at 6 months persisted significantly decreased when compared to the control group, and no significant differences were found with the 0 months evaluation; in addition, when analyzed separately, women showed a worsening in the VD. Moreover, a significantly greater FAZ (p = 0.003) was observed in COVID-19 patients at 6 months, compared to 0 months.
Conlusions
These findings confirm clinical findings suggesting that thrombotic and inflammatory phenomena happen in the retina of COVID-19 patients. These microvascular alterations can be detected and quantified by OCTA and they persist over time and are still evident 6 months after hospital discharge. Further research is warranted to analyze the longitudinal evolution of these changes over time as well as their correlation with disease severity.
Financial Disclosure
None to disclose
Comments
-